QuidelOrtho announces termination of President and CEO Douglas Bryant

The Board of Directors of QuidelOrtho Corporation has made significant decisions aimed to enhance operational efficiency, drive revenue growth and deliver shareholder value. After a comprehensive evaluation, the Board has terminated Douglas Bryant, President and Chief Executive Officer of QuidelOrtho. Mr. Bryant has also resigned from the Board, both effective February 21. To ensure business continuity and effective leadership, the Board formed the Office of the Chief Executive Officer on February 17. The Office of the CEO is led by the Company’s Executive Vice President and Chief Commercial Officer, Michael Iskra, Executive Vice President and Chief Operating Officer, Robert Bujarski, and Chief Financial Officer, Joseph Busky. In this transition, Michael Iskra has been appointed as the Interim Chief Executive Officer, and Robert Bujarski as the Interim President, effective February 21…. Both will continue to fulfill their current responsibilities while assuming the additional duties of their new roles. Kenneth F. Buechler, Ph.D., will remain as Chairman of the Board and will provide guidance to the Office of the CEO, supported by other Board members. The Board has started a comprehensive search to identify a new Chief Executive Officer, considering both internal and external candidates. There is no change to the Company’s financial guidance provided on February 16 …Additionally, the Company will postpone its previously announced Investor Day until a later date.